Send feedback

ADGRE2 p.Pro754=

c.2262G>A · rs199725081 · VCV3021722

Likely benign Single submitter
Classification
Likely benign
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
gnomAD v4.1
Rare
ultra-rare (popmax 0.0164%, mid)

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -20GERP -3.7
Overall
CADD6.444PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0164% Middle Eastern · 1/6,084 alleles
Filtering AF 0.00716% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00668%
Overall 0.00725% 117/1,614,032 alleles · ultra-rare
Ancestry group Frequency 1 in
Middle Easterngrpmax 0.0164% 6,084
South Asian 0.00988% 10,120
European (non-Finnish) 0.00856% 11,683
Admixed American 0.00333% 29,988
African / African-American 0.00267% 37,460
East Asian 0.00223% 44,888
Remaining individualsnot grpmax-eligible 0.0016% 62,488

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
ADGRE2
Protein
p.Pro754=
Coding
c.2262G>A
MANE Select
NM_013447
dbSNP
rs199725081
Type
single nucleotide variant
Location
chr19:14743706 (GRCh38)
Gene constraint
LOEUF 1.028 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 79.44 · 3 PDB
Full ADGRE2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/adgre2-p-pro754 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown